AJR Am J Roentgenol
- KUBALE R, Schneider G, Lessenich CPN, Buecker A, et al
Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective
Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous
Population.
AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.23.30775.
Am J Gastroenterol
- TABISH M, Agarwal S, Gopi S, Rana R, et al
Randomized controlled trial of Intravenous ferric-carboxymaltose vs oral iron to
treat iron deficiency anemia after variceal bleed in patients with cirrhosis.
Am J Gastroenterol. 2024 Mar 22. doi: 10.14309/ajg.0000000000002775.
BMC Cancer
- MA Y, Gong Y, Qiu Q, Ma C, et al
Research on multi-model imaging machine learning for distinguishing early
hepatocellular carcinoma.
BMC Cancer. 2024;24:363.
- FU J, Zheng L, Tang S, Lin K, et al
Tumor burden score and carcinoembryonic antigen predict outcomes in patients with
intrahepatic cholangiocarcinoma following liver resection: a multi?institutional
analysis.
BMC Cancer. 2024;24:358.
- LIANG Y, Zhong D, Zhang Z, Su Y, et al
Correction: Impact of preoperative antiviral therapy on the prognosis of
hepatitis B virus-related hepatocellular carcinoma.
BMC Cancer. 2024;24:343.
BMC Gastroenterol
- LI XM, Liu SL, He YJ, Shu JC, et al
Using new indices to predict metabolism dysfunction-associated fatty liver
disease (MAFLD): analysis of the national health and nutrition examination survey
database.
BMC Gastroenterol. 2024;24:109.
- FENG Z, Zhao F, Wang Z, Tang X, et al
The relationship between sarcopenia and metabolic dysfunction-associated fatty
liver disease among the young and middle-aged populations.
BMC Gastroenterol. 2024;24:111.
Br J Surg
- MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
Histopathological, Clinical, And Molecular (HICAM) score for patients with
colorectal liver metastases.
Br J Surg. 2024;111:znae016.
Dig Dis Sci
- ARSHAD T, Vainer D, Khan H, Baral A, et al
Development of Clinical Algorithm Utilizing Vibration-Controlled Transient
Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
Endoscopy
- WILEN J, Trieu JA, Baron TH
Endoscopic ultrasound-guided embolization of a gastric varix by injection of
RADA16 self-assembling peptide and coils.
Endoscopy. 2024;56.
Eur J Pediatr
- ZAHMATKESH A, Sohouli MH, Shojaie S, Rohani P, et al
The effect of orlistat in the treatment of non-alcoholic fatty liver in
adolescents with overweight and obese.
Eur J Pediatr. 2024;183:1173-1182.
Eur Radiol
- KIM TH, Woo S, Lee DH, Do RK, et al
MRI imaging features for predicting macrotrabecular-massive subtype
hepatocellular carcinoma: a systematic review and meta-analysis.
Eur Radiol. 2024 Mar 20. doi: 10.1007/s00330-024-10671.
- NAKAZAWA Y, Okada M, Hyodo T, Tago K, et al
Comparison between CT volumetry, technetium(99m) galactosyl-serum-albumin
scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis
stage in preoperative patients.
Eur Radiol. 2024;34:2212-2222.
- CARUSO D, De Santis D, Del Gaudio A, Guido G, et al
Low-dose liver CT: image quality and diagnostic accuracy of deep learning image
reconstruction algorithm.
Eur Radiol. 2024;34:2384-2393.
- RATA M, De Paepe KN, Orton MR, Castagnoli F, et al
Evaluation of simultaneous multi-slice acquisition with advanced processing for
free-breathing diffusion-weighted imaging in patients with liver metastasis.
Eur Radiol. 2024;34:2457-2467.
Gastroenterology
- LLOVET JM, Heikenwalder M
Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific
Etiology.
Gastroenterology. 2023;165:1308-1310.
Gastrointest Endosc
- NORSA L, Morotti F, Mantegazza C, Meroni M, et al
Mobile Health technology in pediatric esophagogastroduodenoscopy quality
indicators assessment: results from a national program of the Italian Society of
Pediatric Gastroenterology, Hepatology and Nutrition.
Gastrointest Endosc. 2024 Mar 19:S0016-5107(24)00180.
Hepatology
-
April 2024 Hepatology Highlights.
Hepatology. 2024;79:745-746.
-
Erratum: HCC EV ECG score: An extracellular vesicle-based protein assay for
detection of early-stage hepatocellular carcinoma.
Hepatology. 2024;79:E127.
-
Erratum: Identification and characterization of a hepatic IL-13-producing
ILC3-like population potentially involved in liver fibrosis.
Hepatology. 2024;79:E128.
- MEROUEH C, Warasnhe K, Tizhoosh HR, Shah VH, et al
Digital pathology and spatial omics in steatohepatitis: Clinical applications and
discovery potentials.
Hepatology. 2024 Mar 22. doi: 10.1097/HEP.0000000000000866.
- LADD AD, Duarte S, Sahin I, Zarrinpar A, et al
Mechanisms of drug resistance in HCC.
Hepatology. 2024;79:926-940.
- VOLKERT I, Fromme M, Schneider C, Candels L, et al
Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease
progression.
Hepatology. 2024;79:898-911.
- FRANSES JW, Duda DG
Scirrhous HCC: Another 'omic thread in the HCC tapestry.
Hepatology. 2024;79:747-748.
- ZHUANG Y, Ortega-Ribera M, Thevkar Nagesh P, Joshi R, et al
Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory
responses and fibrosis in cholestasis-induced liver and kidney injury via
regulation of ZBP1.
Hepatology. 2023 Sep 19. doi: 10.1097/HEP.0000000000000611.
- ALKHOURI N, Harisinghani M
Letter to the Editor: Comparing quantitative MRI technologies in steatotic liver
disease.
Hepatology. 2024;79:E119-E120.
- LI J, Allen AM, Yin M
Reply: Comparing quantitative MRI technologies in steatotic liver disease.
Hepatology. 2024;79:E121-E122.
J Clin Oncol
- GORDAN JD, Kennedy EB, Abou-Alfa GK, Beal E, et al
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
J Clin Oncol. 2024 Mar 19:JCO2302745. doi: 10.1200/JCO.23.02745.
J Gastroenterol Hepatol
- SUZUKI K, Yasui Y, Tsuchiya K, Matsumoto H, et al
Impact of immune-related adverse events in patients with hepatocellular carcinoma
treated with atezolizumab plus bevacizumab.
J Gastroenterol Hepatol. 2024 Mar 17. doi: 10.1111/jgh.16532.
J Hepatol
- XU L, Zhang Y, Lin Z, Deng X, et al
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis
sinensis infection-related intrahepatic cholangiocarcinoma.
J Hepatol. 2024 Mar 18:S0168-8278(24)00199-5. doi: 10.1016/j.jhep.2024.
- YASHASWINI CN, Qin T, Bhattacharya D, Amor C, et al
Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic
dysfunction-associated steatotic liver disease.
J Hepatol. 2024 Mar 18:S0168-8278(24)00197-1. doi: 10.1016/j.jhep.2024.
- YANG A, Zhu X, Zhang L, Ding Y, et al
Transitioning from NAFLD to MAFLD and MASLD: Consistent prevalence and risk
factors in a Chinese cohort.
J Hepatol. 2024;80:e154-e155.
- KIRK FT, Munk DE, Swenson ES, Quicquaro AM, et al
Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in
patients with Wilson disease.
J Hepatol. 2024;80:586-595.
- RETAT L, Webber L, Jepsen P, Martin A, et al
Preventing liver disease with policy measures to tackle alcohol consumption and
obesity: The HEPAHEALTH II study.
J Hepatol. 2024;80:543-552.
- CHEN J, Zhou H, Liu K
Normal weight and central obesity as predictors of increased all-cause mortality
in metabolic dysfunction associated steatotic liver disease.
J Hepatol. 2024;80:e143-e145.
- SUZUKI H, Tanaka T, Yamaguchi S, Miwa K, et al
Changing from NAFLD to MASLD: Similar prognosis of unresectable extrahepatic
gastrointestinal cancer under chemotherapy between NAFLD and MASLD.
J Hepatol. 2024;80:e150-e151.
- SHIRI AM, Zhang T, Bedke T, Zazara DE, et al
IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1
induction.
J Hepatol. 2024;80:634-644.
- WANG CW, Huang PC, Dai CY, Huang JF, et al
Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN,
NASPGHAN, and NAFLD - identifying the optimal pediatric label.
J Hepatol. 2024;80:e157-e159.
- TREVISANI F, Vitale A, Kudo M, Kulik L, et al
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from
the past to improve the future with a novel proposal.
J Hepatol. 2024;80:661-669.
- NAYAGAM JS, Miquel R, Thompson RJ, Joshi D, et al
Genetic cholestasis in children and adults.
J Hepatol. 2024 Jan 30:S0168-8278(23)05305-9. doi: 10.1016/j.jhep.2023.
- MOGA L, Paradis V, Bruno O, Valla D, et al
Hepatomegaly in a patient with a history of acute myeloid leukemia.
J Hepatol. 2024;80:e139-e142.
PLoS Genet
- SMAGRIS E, Shihanian LM, Mintah IJ, Bigdelou P, et al
Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human
and mouse.
PLoS Genet. 2024;20:e1011179.
PLoS One
- YANG X, Wang S, Sun C, Xia Y, et al
Causal effect of porphyria biomarkers on alcohol-related hepatocellular carcinoma
through Mendelian Randomization.
PLoS One. 2024;19:e0299536.
Radiology
- LIU F, Bi M, Jing X, Ding H, et al
Multiparametric US for Identifying Metabolic Dysfunction-associated
Steatohepatitis: A Prospective Multicenter Study.
Radiology. 2024;310:e232416.
- REUTER KL
Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis
Globally.
Radiology. 2024;310:e240436.
Semin Liver Dis
- KODAMA T, Takehara T
Molecular genealogy of metabolic-associated hepatocellular carcinoma.
Semin Liver Dis. 2024 Mar 18. doi: 10.1055/a-2289-2298.
Transplant Proc
- HO CT, Vu VQ, Dang KK, Pham HM, et al
Effect of Donors' Biliary Variation on Postoperative Biliary Complications in
Living Donor Liver Transplantation: A Single-Center Observational Study in
Vietnam.
Transplant Proc. 2024 Feb 23:S0041-1345(24)00065.
- UENO T, Takase K, Deguchi K, Nomura M, et al
Clinical Implications of Serum Mac-2 Binding Protein in Patients After Living
Donor Liver Transplantation for Biliary Atresia.
Transplant Proc. 2024 Feb 14:S0041-1345(24)00006.
- RODRIGUEZ-ESPINOSA D, Morantes L, Garcia J, Broseta JJ, et al
Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney
Transplant Recipients.
Transplant Proc. 2024 Feb 12:S0041-1345(24)00004.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016